Author:
Uharek L.,Gassmann W.,Glass B.,Focks B.,Bolouri H.,Loeffler H.,Mueller-Ruchholtz W.
Publisher
Springer Berlin Heidelberg
Reference21 articles.
1. Bortin MM, Horowitz MM, Gale RP (1989) Current status of bone marrow transplantation in humans: report from the international bone marrow transplant registry. Nat Immun Cell Growth Regul 7: 334
2. Weiden PL et al. (1979) Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 300: 1068
3. Mitsuyasu RT, Champlin RE, Gale RP, Ho WG, Lenarsky C, Winston D, Selch M, Elashoff R, Giorgi JV, Wells J, Terasaki P, Billing R, Feig S (1986) Treatment of donor bone marrow with monoclonal anti T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double blind trial. Ann Intern Med 105: 20
4. Prentice HG, Hermans J, Zwaan FE (1988) Relapse risk in allogeneic BMT with T cell depletion of donor marrow. Bone Marrow Transplant [Suppl] 3: 30
5. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb H-J, Rimm AA, Ringdén O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM (1990) Graft-versus-leukemia reactions after bone marrow trans plantation. Blood 75: 555